Anthem Blue Cross and Blue Shield New Hampshire prior authorization, page 15

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0895TConnection of liver allograft to normothermic machine perfusion device, hemostasis control; initial 4 hours of monitoring time, including hourly physiological and laboratory assessments (eg, perfusate temperature, perfusate pH, hemodynamic parameters, bile production, bile pH, bile glucose, biliary bicarbonate, lactate levels, macroscopic assessment)New Hampshire Precertification List, Pg 76 Original policy
0899TNoninvasive Determination of absolute quantitation of myocardial blood flow (AQMBF) derived from augmentative algorithmicNew Hampshire Precertification List, Pg 76 Original policy
0900TNoninvasive Determination of absolute quantitation of myocardial blood flow (AQMBF) derived from assistive algorithmicNew Hampshire Precertification List, Pg 76 Original policy
0908TOpen implantation of integrated neurostimNew Hampshire Precertification List, Pg 76 Original policy
0909TReplacement of integrated neurostimulatioNew Hampshire Precertification List, Pg 76 Original policy
0910TRemoval of integrated neurostimulation syNew Hampshire Precertification List, Pg 76 Original policy
0911TElectronic analysis of implanted integratedNew Hampshire Precertification List, Pg 76 Original policy
0912TElectronic analysis of implanted integratedNew Hampshire Precertification List, Pg 76 Original policy
0913TPercutaneous transcatheter therapeutic drNew Hampshire Precertification List, Pg 76 Original policy
0915TInsertion of permanent cardiac contractility modulation-defibrillation system component(s), including fluoroscopic guidance, and evaluation and programming of sensing and therNew Hampshire Precertification List, Pg 76 Original policy
0916TInsertion of permanent cardiac contractility modulation-defibrillation system component(s), including fluoroscopic guidance, and evaluation and programming of sensing and therNew Hampshire Precertification List, Pg 76 Original policy
0917TInsertion of permanent cardiac contractility modulation-defibrillation system component(s), including fluoroscopic guidance, and evaluation and programming of sensing and therNew Hampshire Precertification List, Pg 77 Original policy
0918TInsertion of permanent cardiac contractility modulation-defibrillation system component(s), including fluoroscopic guidance, and evaluation and programming of sensing and therNew Hampshire Precertification List, Pg 77 Original policy
0919TRemoval of a permanent cardiac contractility modulation-defibrillation system component(s); pulse generator onlyNew Hampshire Precertification List, Pg 77 Original policy
0920TRemoval of a permanent cardiac contractility modulation-defibrillation system component(s); single transvenous pacing lead onlyNew Hampshire Precertification List, Pg 77 Original policy
0921TRemoval of a permanent cardiac contractility modulation-defibrillation system component(s); single transvenous defibrillation lead onlyNew Hampshire Precertification List, Pg 77 Original policy
0922TRemoval of a permanent cardiac contractility modulation-defibrillation system component(s); dual (pacing and defibrillation) transvenous leads onlyNew Hampshire Precertification List, Pg 77 Original policy
0923TRemoval and replacement of permanent cardiac contractility modulationdefibrillation pulse generator onlyNew Hampshire Precertification List, Pg 77 Original policy
0924TRepositioning of previously implanted cardiac contractility modulation- defibrillation transvenous electrode(s)/lead(s), including fluoroscopic guidance and programming of sensNew Hampshire Precertification List, Pg 77 Original policy
0925TRelocation of skin pocket for implanted cardiac contractility modulation- defibrillation pulse generatorNew Hampshire Precertification List, Pg 77 Original policy
0926TProgramming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed valuesNew Hampshire Precertification List, Pg 77 Original policy
0927TInterrogation device evaluation (in person) with analysis, review, and report, including connection, recording, and disconnection, per patient encounter, implantable cardiac cNew Hampshire Precertification List, Pg 77 Original policy
0928TInterrogation device evaluation (remote), up to 90 days, cardiac contractility modulation-defibrillation system with interim analysis and report(s) by a physician or other quaNew Hampshire Precertification List, Pg 77 Original policy
0929TInterrogation device evaluation (remote), up to 90 days, cardiac contractility modulation-defibrillation system, remote data acquisition(s), receipt of transmissions, techniciNew Hampshire Precertification List, Pg 78 Original policy
0930TElectrophysiologic evaluation of cardiac contractility modulation-defibrillator leads, including defibrillation-threshold evaluation (induction of arrhythmia, evaluation of seNew Hampshire Precertification List, Pg 78 Original policy
0931TElectrophysiologic evaluation of cardiac contractility modulation-defibrillator leads, including defibrillation-threshold evaluation (induction of arrhythmia, evaluation of seNew Hampshire Precertification List, Pg 78 Original policy
0933TTranscatheter implantation of wireless left atrial pressure sensor for long-term left atrial pressure monitoring, including sensor calibration and deployment, right heart cathNew Hampshire Precertification List, Pg 78 Original policy
0934TRemote monitoring of a wireless left atrial pressure sensor for up to 30 days, including data from daily uploads of left atrial pressure recordings, interpretation(s) and trenNew Hampshire Precertification List, Pg 78 Original policy
0935TCystourethroscopy with renal pelvic sympathetic denervation, radiofrequency ablation, retrograde ureteral approach, including insertion of guide wire, selective placementNew Hampshire Precertification List, Pg 78 Original policy
0948TInterrogation device evaluation (remote), uNew Hampshire Precertification List, Pg 78 Original policy
0949TInterrogation device evaluation (remote), uNew Hampshire Precertification List, Pg 78 Original policy
0951TTotally implantable active middle ear hearing implant; initial placement, including mastoidectomy, placement of and attachment to sound processorNew Hampshire Precertification List, Pg 78 Original policy
0952TTotally implantable active middle ear hearing implant; revision or replacement, with mastoidectomy and replacement of sound processorNew Hampshire Precertification List, Pg 78 Original policy
0953TTotally implantable active middle ear hearing implant; replacement of sound processor only, with attachment to existing transducersNew Hampshire Precertification List, Pg 78 Original policy
0954TTotally implantable active middle ear hearing implant; replacement of sound processor only, with attachment to existing transducersNew Hampshire Precertification List, Pg 78 Original policy
0955TTotally implantable active middle ear hearing implant; removal, including removal of sound processor and all implant componentsNew Hampshire Precertification List, Pg 78 Original policy
0964TImpression and custom preparation of jawNew Hampshire Precertification List, Pg 78 Original policy
0965TImpression and custom preparation of jawNew Hampshire Precertification List, Pg 78 Original policy
0966TImpression and custom preparation of jawNew Hampshire Precertification List, Pg 79 Original policy
0970TAblation, benign breast tumor (eg, fibroadenoma), percutaneous, laser, including imaging guidance when performed, each tumorNew Hampshire Precertification List, Pg 79 Original policy
0971TAblation, malignant breast tumor(s), percutaneous, laser, including imaging guidance when performed, unilateralNew Hampshire Precertification List, Pg 79 Original policy
0978TSubmucosal cryolysis therapy; soft palate, base of tongue, and lingual tonsilNew Hampshire Precertification List, Pg 79 Original policy
0979TSubmucosal cryolysis therapy; soft palate onlyNew Hampshire Precertification List, Pg 79 Original policy
0980TSubmucosal cryolysis therapy; base of tongue and lingual tonsil onlyNew Hampshire Precertification List, Pg 79 Original policy
11920Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.0 sq cm or lessNew Hampshire Precertification List, Pg 79 Original policy
11921Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.1 to 20.0 sq cmNew Hampshire Precertification List, Pg 79 Original policy
11950Subcutaneous injection of filling material (eg, collagen); 1 cc or lessNew Hampshire Precertification List, Pg 79 Original policy
11951Subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 ccNew Hampshire Precertification List, Pg 79 Original policy
11952Subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 ccNew Hampshire Precertification List, Pg 79 Original policy
11954Subcutaneous injection of filling material (eg, collagen); over 10.0 ccNew Hampshire Precertification List, Pg 79 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.